Your browser doesn't support javascript.
loading
The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation.
Ji, Qiuyi; Zhang, Chunyu; Xu, Qing; Wang, Zi; Li, Xiaoye; Lv, Qianzhou.
Affiliation
  • Ji Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
  • Zhang C; Department of Cardiology, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
  • Xu Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
  • Wang Z; Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
  • Li X; Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
  • Lv Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai, China.
Br J Clin Pharmacol ; 87(5): 2247-2255, 2021 05.
Article in En | MEDLINE | ID: mdl-33179295

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Dabigatran Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2021 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Dabigatran Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2021 Type: Article Affiliation country: China